The Jikei University School of Medicine at ESGCT 2026
Oct 27–30, 2026 Hamburg, Germany ~2.5k attendees Website
The Jikei University School of Medicine brings 2 presentations to ESGCT 2026 in Hamburg. Its work addresses inherited lysosomal storage disease. One topic is blood stem cell gene therapy delivering an enzyme fused to an anti-transferrin-receptor antibody, which clears brain pathology in a GM1 gangliosidosis model.
| Organization | ESGCT 2026 Attendance |
|---|---|
The Jikei University School of Medicine Tokyo, Japan | |
Private medical university in Tokyo with research on gene therapy for lysosomal storage diseases. | Talk Tue Oct 27 6:00pm–7:30pm Research and Development of Gene Therapy for Lysosomal Storage Diseases Rare and inherited disease Poster Wed Oct 28 1:30pm–3:30pm Hematopoietic Stem Cell Gene Therapy with Anti‑TfR–Fused Enzyme Restores CNS Pathology in GM1 Gangliosidosis model mice |
Instantly find 20 buyers from The Jikei University School of Medicine
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the European Society of Gene & Cell Therapy. Submit a correction